Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Marsden

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 17, 2005
Infantile onset Pompe disease: a report of physician narratives from an epidemiologic studyDeborah Marsden
The Southeast Asian Journal of Tropical Medicine and Public Health|May 24, 2005
Expanded newborn screening by tandem mass spectrometry: the Massachusetts and New England experienceDeborah Marsden
Critical Reviews in Clinical Laboratory Sciences|March 4, 2009
Newborn screeningInderneel Sahai, Deborah Marsden
Clinical Chemistry|May 22, 2010
Newborn screening of lysosomal storage disordersDeborah Marsden, Harvey Levy
Molecular Genetics and Metabolism|April 1, 2020
Urinary glycosaminoglycans as a potential biomarker for evaluating treatment efficacy in subjects with mucopolysaccharidosesEmil Kakkis, Deborah Marsden
Pediatric Annals|August 29, 2003
Expanded newborn screeningMarsha K Fearing, Deborah Marsden
Clinical Chemistry|February 26, 2004
Emerging role for tandem mass spectrometry in detecting congenital adrenal hyperplasiaDeborah Marsden, Cecilia A Larson
Advances in Therapy|June 8, 2022
Estimating the Prevalence of Rare Diseases: Long-Chain Fatty Acid Oxidation Disorders as an Illustrative ExampleEliza Kruger, Paul McNiven, Deborah Marsden
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 26, 2021
Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disordersDeborah Marsden, Camille L Bedrosian, Jerry Vockley
The Journal of Pediatrics|June 2, 2006
Newborn screening for metabolic disordersDeborah Marsden, Cecilia Larson, Harvey L Levy
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 17, 2005
Infantile onset Pompe disease: a report of physician narratives from an epidemiologic studyDeborah Marsden
The Southeast Asian Journal of Tropical Medicine and Public Health|May 24, 2005
Expanded newborn screening by tandem mass spectrometry: the Massachusetts and New England experienceDeborah Marsden
Critical Reviews in Clinical Laboratory Sciences|March 4, 2009
Newborn screeningInderneel Sahai, Deborah Marsden
Clinical Chemistry|May 22, 2010
Newborn screening of lysosomal storage disordersDeborah Marsden, Harvey Levy
Molecular Genetics and Metabolism|April 1, 2020
Urinary glycosaminoglycans as a potential biomarker for evaluating treatment efficacy in subjects with mucopolysaccharidosesEmil Kakkis, Deborah Marsden
Pediatric Annals|August 29, 2003
Expanded newborn screeningMarsha K Fearing, Deborah Marsden
Clinical Chemistry|February 26, 2004
Emerging role for tandem mass spectrometry in detecting congenital adrenal hyperplasiaDeborah Marsden, Cecilia A Larson
Advances in Therapy|June 8, 2022
Estimating the Prevalence of Rare Diseases: Long-Chain Fatty Acid Oxidation Disorders as an Illustrative ExampleEliza Kruger, Paul McNiven, Deborah Marsden
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 26, 2021
Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disordersDeborah Marsden, Camille L Bedrosian, Jerry Vockley
The Journal of Pediatrics|June 2, 2006
Newborn screening for metabolic disordersDeborah Marsden, Cecilia Larson, Harvey L Levy
Pageof 4